especially in image-based applications where data may be limited. While numerous CNNs have been trained on large datasets for brain tumor detection, the inherent similarities between normal and ...

--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, presented data today from a study showing that its methylation-based Shield™ multi-cancer detection ...